Richard Mould

Richard Mould is a Senior Scientist with extensive experience in the field of pharmacology and drug discovery. Currently at MSD since September 2019, Richard has also been with Sosei Heptares since July 2009, where responsibilities include overseeing screening and pharmacological profiling for multiple GPCR projects. Previously, Richard held positions as an Associate Enzymologist at Astex Therapeutics and as an In-vitro Pharmacologist at Pfizer. Richard holds a Bachelor of Science degree in Applied Biology from the University of Reading, awarded between 2002 and 2005.